<DOC>
	<DOCNO>NCT01767493</DOCNO>
	<brief_summary>The purpose study evaluate feasibility [ 18F ] Florbetapir positron emission tomography ( PET ) assessment demyelination patient relapse remit multiple sclerosis .</brief_summary>
	<brief_title>Study Evaluate Feasibility 18FFlorbetapir PET Assessment MS Patients</brief_title>
	<detailed_description>The underlying goal study assess feasibility [ 18F ] Florbetapir image tool detect demyelination brain MS research participant compare similarly age healthy subject .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis , Relapsing-Remitting</mesh_term>
	<criteria>Eligibility criterion ( subject ) : Ability understand purpose risk study provide sign date informed consent authorization use protect health information accordance national local subject privacy regulation Willingness comply study procedure Willingness provide write informed consent Age great equal 18 less equal 60 year old time inform consent Subjects childbearing potential must practice effective contraception study willing able continue contraception PET testing complete For female , must nonchildbearing potential negative urine blood pregnancy test day [ 18F ] Florbetapir PET injection Inclusion Criteria ( Healthy Volunteers ) : No history sign acute chronic neurological psychiatric illness base evaluation research physician . Inclusion Criteria ( MS Subjects ) : Have diagnosis relapse remit MS accord 2010 MacDonald Criteria Have least 10 demyelinate lesion brain MRI follow characteristic : Hypointense T2 weight image FLAIR Exclusion Criteria ( subject ) : The subject clinically significant abnormal laboratory value and/or clinically significant unstable medical psychiatric illness The subject evidence clinically significant gastrointestinal , cardiovascular , hepatic , renal , hematological , neoplastic , endocrine , alternative neurological ( RRMS ) , immunodeficiency , pulmonary , disorder disease . Women pregnant actively breastfeed The subject disorder may interfere drug absorption , distribution , metabolism , excretion ( include gastrointestinal surgery ) The subject participate another clinical study within previous 30 day Renal impairment creatine clearance &lt; 80mL/minute screening ( creatine clearance estimate CockcroftGault equation ) The subject schedule major surgery procedure time study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Multiple sclerosis</keyword>
</DOC>